Align Technology price to free cash flow ALGN

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 17.3×
10-year median: 45.2×
Against its 10-year history: 4th; percentile: 0 is its lowest day, 100 its highest
10-year range: 14.4× to 138×
Peer median: 19.8×

Align Technology's price to free cash flow is 17.3× as of Oct 23, 2026.

That is below its ten-year median of 45.2×, lower than on 96% of days in the last ten years.

Over that time it ranged from 14.4× in Oct 2025 to 138× in Feb 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 19.8×.

Price to free cash flow over time

median 45.2×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	17.3×	16.0×	27.6×
2025	20.1×	14.4×	46.7×
2024	42.3×	29.5×	47.1×
2023	30.6×	21.4×	98.3×
2022	47.2×	29.6×	59.1×
2021	55.4×	51.3×	138×
2020	119×	19.1×	119×
2019	35.9×	31.5×	86.0×
2018	70.3×	67.2×	119×
2017	82.2×	41.9×	99.9×
2016	44.3×	25.1×	46.6×
2015	28.1×	21.0×	28.8×
2014	22.6×	19.2×	34.8×
2013	31.1×	25.0×	36.5×
2012	26.2×	19.8×	39.5×
2011	19.9×	12.0×	21.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Align Technology's size, closest first, today.

Company	Price to free cash flow
ALGNAlign Technology	17.3×
GMEDGlobus Medical	14.5×
COOCooper Companies	17.2×
PODDInsulet	35.2×
PENPenumbra	59.2×
SOLVSolventum	n/m
MSAMSA Safety	19.8×
MMSIMerit Medical Systems	27.4×
HAEHaemonetics	18.5×
VNTVontier	12.1×
BMIBadger Meter	29.2×
Peer median	19.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Align Technology

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.